News

World leaders in ending blood cancer

A device transforms a patient’s white blood cells into a CAR T-cell therapy in several days in the Siteman Cancer Center Biologic Therapy Core Facility. This supports translational medicine efforts — from bench to bedside — in the fields of cellular therapy and gene therapy for treating blood cancers.
View Content

The Siteman Blood Cancer Center delivers tomorrow’s treatments today.

The Siteman Blood Cancer Center, recognized internationally as a leader in innovative care, draws patients from across the U.S. and overseas. The center brings together the multidisciplinary expertise of WashU Medicine physicians who have a singular focus on treating blood cancers, including leukemia, lymphoma, multiple myeloma and myelodysplastic syndromes. They have long been at the forefront of transforming care and pushing the boundaries of what’s possible in managing these complex cancers.